New Drug ApprovalFDA Approves Tecentriq as First ctDNA-Guided Therapy for Bladder Cancer FDA Approves Tecentriq as First ctDNA-Guided Therapy for Bladder Cancer Read Post »
New Drug ApprovalMHRA Approves Vyjuvek for Dystrophic Epidermolysis Bullosa MHRA Approves Vyjuvek for Dystrophic Epidermolysis Bullosa Read Post »
New Drug ApprovalFDA Approves Enhertu After Positive DESTINY-Breast Phase III Results FDA Approves Enhertu After Positive DESTINY-Breast Phase III Results Read Post »
New Drug ApprovalTaiho’s INQOVI With Venetoclax Approved for Patients Unable to Receive In... Taiho’s INQOVI With Venetoclax Approved for Patients Unable to Receive In... Read Post »
New Drug ApprovalBeOne Gains FDA Accelerated Approval for BEQALZI in MCL BeOne Gains FDA Accelerated Approval for BEQALZI in MCL Read Post »
New Drug ApprovalEuropean Commission Approves Pfizer’s HYMPAVZI for Haemophilia Patients European Commission Approves Pfizer’s HYMPAVZI for Haemophilia Patients Read Post »
New Drug ApprovalHenlius Secures EU Approval for Serplulimab in Lung and Esophageal Cancers Henlius Secures EU Approval for Serplulimab in Lung and Esophageal Cancers Read Post »
New Drug ApprovalFDA Approves Bizengri for Rare NRG1-Positive Cholangiocarcinoma FDA Approves Bizengri for Rare NRG1-Positive Cholangiocarcinoma Read Post »
New Drug ApprovalFDA Approves VYVGART for All Adult gMG Antibody Subtypes FDA Approves VYVGART for All Adult gMG Antibody Subtypes Read Post »
New Drug ApprovalGenentech Wins FDA Approval for Ocrevus in Pediatric Multiple Sclerosis Genentech Wins FDA Approval for Ocrevus in Pediatric Multiple Sclerosis Read Post »
New Drug ApprovalEU Clears BMS’s Sotyktu for Adults With Psoriatic Arthritis EU Clears BMS’s Sotyktu for Adults With Psoriatic Arthritis Read Post »
New Drug ApprovalInnovent Wins NMPA Approval for Multi-Dose Mazdutide Pen in Type 2 Diabetes Innovent Wins NMPA Approval for Multi-Dose Mazdutide Pen in Type 2 Diabetes Read Post »
New Drug ApprovalNICE Recommends Givinostat for Ambulant DMD Patients Aged 6+ via NHS Innova... NICE Recommends Givinostat for Ambulant DMD Patients Aged 6+ via NHS Innova... Read Post »
New Drug ApprovalMHRA Authorizes Dawnzera for Patients With Hereditary Angioedema MHRA Authorizes Dawnzera for Patients With Hereditary Angioedema Read Post »
New Drug ApprovalBridgeBio Gains ANVISA Clearance in Brazil for BEYONTTRA in ATTR-CM BridgeBio Gains ANVISA Clearance in Brazil for BEYONTTRA in ATTR-CM Read Post »
New Drug ApprovalASCENIV Approved for Expanded Pediatric Use in Primary Immunodeficiency ASCENIV Approved for Expanded Pediatric Use in Primary Immunodeficiency Read Post »
New Drug ApprovalFDA Clears VEPPANU, First PROTAC Therapy, for Advanced Breast Cancer FDA Clears VEPPANU, First PROTAC Therapy, for Advanced Breast Cancer Read Post »
New Drug ApprovalMHRA Clears Linerixibat (Lynavoy) for PBC-Related Itch in Adults MHRA Clears Linerixibat (Lynavoy) for PBC-Related Itch in Adults Read Post »
New Drug ApprovalJohnson & Johnson Secures FDA Nod for STELARA in Pediatric Crohn’s Johnson & Johnson Secures FDA Nod for STELARA in Pediatric Crohn’s Read Post »
New Drug ApprovalRhythm Wins EU Approval for IMCIVREE in Acquired Hypothalamic Obesity Rhythm Wins EU Approval for IMCIVREE in Acquired Hypothalamic Obesity Read Post »
New Drug ApprovalArrowhead Breaks the Triglyceride Barrier with REDEMPLO Approval in Austral... Arrowhead Breaks the Triglyceride Barrier with REDEMPLO Approval in Austral... Read Post »
New Drug ApprovalAxsome Wins FDA Decision for Auvelity in Alzheimer’s Agitation Axsome Wins FDA Decision for Auvelity in Alzheimer’s Agitation Read Post »
New Drug ApprovalNorgine Pushes the Frontier of WHIM Treatment With XOLREMDI EU Approval Norgine Pushes the Frontier of WHIM Treatment With XOLREMDI EU Approval Read Post »
New Drug ApprovalMitsubishi Tanabe Brings Steady Control to Parkinson’s with EU Nod for On... Mitsubishi Tanabe Brings Steady Control to Parkinson’s with EU Nod for On... Read Post »
New Drug ApprovalAstraZeneca’s Triple-combination inhaler Breztri approved by FDA for asth... AstraZeneca’s Triple-combination inhaler Breztri approved by FDA for asth... Read Post »
New Drug ApprovalNovartis Targets the Root of CSU With EU Approval of Rhapsido Novartis Targets the Root of CSU With EU Approval of Rhapsido Read Post »
New Drug ApprovalJohnson & Johnson Gains FDA Nod for CAPLYTA in Schizophrenia Johnson & Johnson Gains FDA Nod for CAPLYTA in Schizophrenia Read Post »
New Drug ApprovalAstraZeneca Clinches FDA Approval for Saphnelo Autoinjector in SLE AstraZeneca Clinches FDA Approval for Saphnelo Autoinjector in SLE Read Post »
New Drug ApprovalCHMP April 2026 Roundup: Breakthroughs in SMA, MS, and Rare Metabolic Disor... CHMP April 2026 Roundup: Breakthroughs in SMA, MS, and Rare Metabolic Disor... Read Post »
New Drug ApprovalRegeneron Breaks the Silence with Otarmeni, a First-in-Class Hearing Loss G... Regeneron Breaks the Silence with Otarmeni, a First-in-Class Hearing Loss G... Read Post »
New Drug ApprovalDupixent Breaks New Ground in Pediatric Chronic Urticaria Care Dupixent Breaks New Ground in Pediatric Chronic Urticaria Care Read Post »
New Drug ApprovalTzield pushes back the clock on T1D in young children with FDA nod Tzield pushes back the clock on T1D in young children with FDA nod Read Post »
New Drug ApprovalIpsen Targets Pediatric Glioma in the EU with Landmark Ojemda Approval Ipsen Targets Pediatric Glioma in the EU with Landmark Ojemda Approval Read Post »
New Drug ApprovalMerck’s IDVYNSO™ Approved for Treatment Switch in Virologically Suppres... Merck’s IDVYNSO™ Approved for Treatment Switch in Virologically Suppres... Read Post »
New Drug ApprovalEU Authorizes Moderna’s mCOMBRIAX for Influenza and COVID-19 in Adults 50... EU Authorizes Moderna’s mCOMBRIAX for Influenza and COVID-19 in Adults 50... Read Post »
New Drug ApprovalBlenrep Gains China Approval for Relapsed/Refractory Multiple Myeloma Blenrep Gains China Approval for Relapsed/Refractory Multiple Myeloma Read Post »
New Drug ApprovalShifting the Treatment Ground: NICE Endorses Oral Pirtobrutinib for CLL Shifting the Treatment Ground: NICE Endorses Oral Pirtobrutinib for CLL Read Post »
New Drug ApprovalEC Approves ENFLONSIA for RSV Prevention in Infants Across Europe EC Approves ENFLONSIA for RSV Prevention in Infants Across Europe Read Post »
New Drug ApprovalNICE Backs Belantamab Mafodotin for Relapsed Multiple Myeloma in NHS NICE Backs Belantamab Mafodotin for Relapsed Multiple Myeloma in NHS Read Post »
New Drug ApprovalFDA Clears Expanded Use of Caldolor for Postoperative Pain Treatment FDA Clears Expanded Use of Caldolor for Postoperative Pain Treatment Read Post »
New Drug ApprovalFILSPARI Unlocks the Door for FSGS With First FDA Approval FILSPARI Unlocks the Door for FSGS With First FDA Approval Read Post »
New Drug ApprovalDupixent Extends Its Reach to Young CSU Patients in EU Dupixent Extends Its Reach to Young CSU Patients in EU Read Post »
New Drug ApprovalMHRA Unleashes Tryngolza to Break the Triglyceride Surge in FCS MHRA Unleashes Tryngolza to Break the Triglyceride Surge in FCS Read Post »
New Drug ApprovalChina Approves GSK’s Exdensur for Chronic Rhinosinusitis with Nasal Polyp... China Approves GSK’s Exdensur for Chronic Rhinosinusitis with Nasal Polyp... Read Post »
New Drug ApprovalSenju Commercializes Avarept 0.3% for Dry Eye Disease in Japan Senju Commercializes Avarept 0.3% for Dry Eye Disease in Japan Read Post »
New Drug ApprovalMHRA Approves Sevabertinib for HER2+ Lung Cancer MHRA Approves Sevabertinib for HER2+ Lung Cancer Read Post »
New Drug ApprovalEU Approves First PD-1–Based Regimen KEYTRUDA for Platinum-Resistant Ovar... EU Approves First PD-1–Based Regimen KEYTRUDA for Platinum-Resistant Ovar... Read Post »
New Drug ApprovalRegeneron Pharmaceuticals Secures FDA Nod for Extended EYLEA HD Dosing Up t... Regeneron Pharmaceuticals Secures FDA Nod for Extended EYLEA HD Dosing Up t... Read Post »
New Drug ApprovalFDA Converts Tecartus Approval to Full Approval in Mantle Cell Lymphoma Fol... FDA Converts Tecartus Approval to Full Approval in Mantle Cell Lymphoma Fol... Read Post »
New Drug ApprovalLilly Brings Weight-Loss Pill to Market with Foundayo FDA Approval Lilly Brings Weight-Loss Pill to Market with Foundayo FDA Approval Read Post »
